What questions should I ask my oncologist about metastatic Kidney Cancer

Key Questions to Ask Your Kidney Cancer Oncologist

Since you have metastatic kidney cancer (cancer that has spread beyond the kidney), here are important questions organized by category to help guide your treatment decisions:

UNDERSTANDING YOUR SPECIFIC CANCER

1. What type of kidney cancer do I have, and what stage is it?

• This determines which treatments are most effective for your situation

2. Has my tumor been tested for genetic mutations or biomarkers?

• Ask specifically about: VHL, PBRM1, BAP1, SETD2, and other mutations
• Understanding your tumor's molecular profile helps identify targeted therapy options
• According to treatment planning frameworks, doctors typically consider genetic testing to identify actionable mutations that point to specific drugs

3. What do my test results show about my tumor's characteristics?

• Request a clear explanation of any genomic (DNA), transcriptomic (RNA), or proteomic (protein) testing
• Ask which results are most important for treatment decisions

TREATMENT OPTIONS & STRATEGY

4. What are my treatment options, and why do you recommend [specific treatment]?

• For metastatic kidney cancer, options typically include:
  • Targeted therapies (drugs that block specific mutations)
  • Immunotherapies (drugs that boost your immune system)
  • Combination approaches
  • Clinical trials

5. Is this a first-line treatment (first treatment I'll receive)?

• Understanding the sequence of treatments helps you plan ahead and preserve options for future rounds of therapy

6. What is the goal of this treatment—to shrink the tumor, slow growth, or manage symptoms?

• This helps set realistic expectations and aligns treatment with your quality-of-life priorities

7. Are there clinical trials available for my specific tumor type and stage?

• Clinical trials may offer access to newer combinations or approaches not yet standard

MONITORING & RESPONSE

8. How will we monitor whether the treatment is working?

• Ask about:
  • Imaging schedules (CT, MRI, PET scans)
  • Blood tests or tumor markers
  • Liquid biopsies (blood tests that detect circulating tumor DNA)
  • How often you'll have scans (typically every 8-12 weeks)

9. What does "response" look like for my treatment, and what timeline should I expect?

• When will you know if the treatment is effective?
• How long before we see changes on imaging?

10. What are the signs that the treatment isn't working, and what's the backup plan?

• Understanding progression helps you prepare for potential treatment changes
• Ask about second-line and third-line options in advance

SIDE EFFECTS & QUALITY OF LIFE

11. What side effects should I expect, and how will we manage them?

• Different treatments have different toxicity profiles
• Ask about:
  • Common vs. serious side effects
  • How to report problems
  • Medications or strategies to manage side effects
  • Impact on daily activities, work, travel

12. Can I continue working, exercising, or traveling during treatment?

• Understanding practical impacts helps you plan your life around treatment

13. Are there any supplements, dietary changes, or lifestyle modifications that could help or hurt my treatment?

• Some supplements can interfere with certain medications
• Nutrition may play a role in treatment tolerance

TESTING & PERSONALIZED APPROACH

14. Should I get additional testing beyond standard workup?

• Ask about:
  • Fresh tissue biopsy (if you have accessible metastases)
  • Functional testing (testing drugs on your actual tumor cells)
  • Comprehensive genomic profiling
  • Immune microenvironment analysis
• According to precision medicine frameworks, getting diverse tests from different perspectives can help identify vulnerabilities in your specific tumor

15. Can you help me access my test results and raw data?

• You have the right to your medical data
• Some patients benefit from having their data analyzed by specialized centers or second-opinion services

LONG-TERM PLANNING

16. What happens if I develop resistance to this treatment?

• What are the next options?
• Should we preserve certain drugs for later use?
• How many treatment lines are typically available?

17. How often should we reassess my treatment plan?

• Standard intervals are often every 3 months with imaging and clinical evaluation
• Ask if your plan includes regular "check-ins" to adjust strategy based on response

18. Should I consider a second opinion?

• This is always reasonable, especially for metastatic disease
• Ask if your oncologist can facilitate this

SHARED DECISION-MAKING

19. What are YOUR priorities for treatment?

• Quality of life vs. aggressive tumor control
• Minimizing side effects vs. maximum efficacy
• Convenience and lifestyle impact
• Being realistic about goals helps align treatment with your values

20. How will we communicate between visits?

• How do you reach your oncologist with questions?
• What symptoms warrant immediate contact?
• How are test results communicated?

---

BRINGING IT ALL TOGETHER

Before your appointment:

• Write down your questions in order of importance
• Bring a notebook or recording device (ask permission first)
• Bring a trusted person to help listen and take notes
• Gather any previous test results or reports

After your appointment:

• Ask for copies of all test results and imaging reports
• Request a written summary of the treatment plan
• Clarify any terms you didn't understand
• Schedule your next appointment before leaving

---

IMPORTANT CONTEXT FOR KIDNEY CANCER

Metastatic kidney cancer treatment has evolved significantly. Modern approaches often combine:

• Targeted therapies that block specific pathways (like VEGF or mTOR pathways)
• Immunotherapies that activate your immune system
• Combination strategies that use both approaches together

The specific recommendation depends on your tumor's molecular characteristics, your overall health, and your personal priorities.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.